Literature DB >> 15784455

World apheresis association--world apheresis registry.

B G Stegmayr1, P Ivanovich, J M Korach, G Rock, R Norda, W Ramlow.   

Abstract

In 2002 WAA decided to start a world-wide apheresis registry to gain insight into the extent of treatment, adverse events, and to facilitate contacts among centers when treatment indications are rare and experience limited. Stem cell and other blood products collections intended for therapeutic application can also be entered. The WAA planned to use the French Registry. Its translation into English has not been accomplished and the fiscal obligations for that registry has not, as yet, been determined or considered and approved by the WAA Board. From Dec 2002 the proposed registry (a merged version of the French, Canadian and Swedish registries) can be immediately implemented. We now cordially invite all centers to join that registry. Please, also inform colleagues at other centers in your country to join. E-mail and address lists of colleagues in your country who have not registered will be welcomed. The site is at: Go to World Apheresis Registry; Login code to test the Registry is: al61tms. Then apply for a specific login code for your center. We welcome you to this registry for your input of data. You will not be charged any registration fee. The registry includes a randomization system that can be used for local or multi center studies (randomization by in-center basis allows you to make your own studies). It includes a formula that increases the chance to get a more even distribution between groups also for smaller sample sizes.

Mesh:

Year:  2005        PMID: 15784455     DOI: 10.1016/j.transci.2004.10.015

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  1 in total

Review 1.  Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis.

Authors:  Bernd Stegmayr; Elizabeth Newman; Volker Witt; Kurt Derfler; Gerda Leitner; Sunny Eloot; Annemieke Dhondt; Dries Deeren; Jan Ptak; Milan Blaha; Mirka Lanska; Zdenka Gasova; Zdenka Bhuiyan-Ludvikova; Radomira Hrdlickova; Wolfgang Ramlow; Heinrich Prophet; Jan T Kielstein; Giancarlo Liumbruno; Elena Mori; Antanas Griskevicius; Judita Audzijoniene; Hans Vrielink; Eva Rombout-Sestrienkova; Astrid Aandahl; Aleksandar Sikole; Jorge Tomaz; Katarina Lalic; Ines Bojanic; Virginia Strineholm; Bo Brink; Gösta Berlin; Josefina Dykes; Thomas Nilsson; Torsten Eich; Henrik Hadimeri; Gunilla Welander; Sandra Ortega Sanchez; Osman Ilhan; Colwyn Poole
Journal:  Transfus Med Hemother       Date:  2021-01-05       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.